SlideShare a Scribd company logo
1 of 45
Dr. Rene V. Yat The Brain and Human Behavior
 
 
 
 
 
 
 
 
 
Parts of basal ganglia
 
 
The brain structures that comprise The Basal Ganglia  ,[object Object],[object Object],[object Object],[object Object],[object Object]
 
Conditions that cause basal ganglia dysfunction ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Brain Disorders associated with Basal ganglia dysfunction ,[object Object],[object Object],[object Object],[object Object],[object Object]
The dopamine pathways in schizophrenia In schizophrenia there is an increase in dopamine transmission between the substantia nigra to the caudate nucleus-putamen (neostriatum) compared with normal. While in the other major dopaminergic pathways — to the mesolimbic forebrain and the tubero-infundibular system — dopamine transmission is reduced. The dopamine hypothesis of schizophrenia proposes that increased levels of dopamine or dopamine receptors in the dorsal and or ventral striatum underlie the disorder.
The glutamate pathways in a brain affected by schizophrenia In the normal brain the prominent glutaminergic pathways are: the cortico-cortical pathways; the pathways between the thalamus and the cortex; and the extrapyramidal pathway (the projections between the cortex and striatum). Other glutamate projections exist between the cortex, substantia nigra, subthalamic nucleus and pallidum.  The glutaminergic pathways are hypoactive in the brains of people diagnosed with schizophrenia and this is thought to cause the confusion and psychosis associated with the disorder.
The serotonergic pathway showing the effects of schizophrenia The two key serotonergic pathways in schizophrenia are the projections from the dorsal raphe nuclei into the substantia nigra and the projections from the rostral raphe nuclei ascending into the cerebral cortex, limbic regions and basal ganglia. The up-regulation of these pathways leads to hypofunction of the dopaminergic system, and this effect may be responsible for the negative symptoms of schizophrenia. The serotonergic nuclei in the brainstem that give rise to descending serotonergic axons remain unaffected in schizophrenia.
 
 
NEUROTRANSMITTERS ,[object Object],[object Object],[object Object]
NEUROTRANSMITTERS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
NEUROTRANSMITTERS ,[object Object],[object Object]
Amino acid NEUROTRANSMITTERS ,[object Object]
NEUROTRANSMITTERS ,[object Object],[object Object],[object Object],[object Object],[object Object]
NEUROTRANSMITTERS ,[object Object],[object Object]
NEUROTRANSMITTERS ,[object Object],[object Object]
NEUROTRANSMITTERS ,[object Object],[object Object]
NEUROTRANSMITTERS ,[object Object],[object Object],[object Object]
Neuropeptides Function of Neuropeptides:     There are cells in the brain that produce various neuropeptides, and these neuropeptides do just about everything.   They can be either pro-inflammatory or anti-inflammatory, with anti-inflammatory being preferred. They are responsible for many functions:   They control our mood, energy levels, pain and pleasure reception, body weight, and ability to solve problems; they also form memories and regulate our immune system.   These active little messengers in the brain actually turn on cellular function in the skin.
Characteristics of Neuropeptides:     Peptides are compounds consisting of two or more amino acids (the building blocks of proteins), chained together by what is called a peptide bond.    Neuropeptides are peptides released by neurons (brain cells) as intercellular messengers. Some neuropeptides function as neurotransmitters, and others function as hormones.    Peptides and neuropeptides, like many substances in our bodies (think cholesterol) can work both for and against us. Anti-inflammatory neuropeptides work for us to reduce inflamation fo the skin.
Transmitter names are shown in bold. Norepinephrine  (noradrenaline). In neurons of the  A2 cell group in the  nucleus of the solitary tract ),  norepinephrine co-exists with: Galanin   Enkephalin   Neuropeptide  Y   GABA Somatostatin  (in the  hippocampus )  Cholecystokinin   Neuropeptide  Y  (in the  arcuate  nucleus )  Acetylcholine VIP   Substance P   - Originally nown as Tachykinins.  Because they are rapidly absorbed they  now known  as neurokinins. They play a key role in modulation of  pain and emotions. Hence possibly in the future this  could be a source of new antidepresants PEPTIDES
Dopamine Cholecystokinin   Neurotensin   Epinephrine  (adrenaline) Neuropeptide  Y   Neurotensin   Serotonin  (5-HT) Substance P   TRH  Enkephalin   PEPTIDES
 
 
UPREGULATION HYPOTHESIS OF NEURONAL RECEPTORS
Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Upregulation theory Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation)
By increasing the amount of neurotransmitter in the cleft, you can normalize responsiveness. Increased neurotransmitter increases stimulation of receptor sites, which prompts the postsynaptic neuron to compensate by decreasing receptor sensitivity, a process known as desensitization  DESENSITIZATION  THEORY
The postsynaptic neuron is also thought to compensate for increasing stimulation by decreasing the number of receptor sites, a process known as down-regulation. Downregulation hypothesis
 
“ Prolonged sitting can cause ischial bursitis”.
“ To study medicine without books and mentors is like a shaman who professes who know everything but deep inside he knows nothing at all.   You can shake, rattle, and roll. But at the end of the day, you wish that you have studied hard for the life you are handling in front of you is not a guinea pig at all”.
END OF THE LECTURE

More Related Content

What's hot

18. endocrine pancreas
18. endocrine pancreas18. endocrine pancreas
18. endocrine pancreas
Nasir Koko
 
Autonomic Nervous System
Autonomic Nervous SystemAutonomic Nervous System
Autonomic Nervous System
Anam_ Khan
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
vacagodx
 

What's hot (20)

Ageing
Ageing Ageing
Ageing
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Alzheimer disease
Alzheimer disease Alzheimer disease
Alzheimer disease
 
18. endocrine pancreas
18. endocrine pancreas18. endocrine pancreas
18. endocrine pancreas
 
Neuropeptides
NeuropeptidesNeuropeptides
Neuropeptides
 
Neurotransmitters and their role
Neurotransmitters and their roleNeurotransmitters and their role
Neurotransmitters and their role
 
Autonomic Nervous System
Autonomic Nervous SystemAutonomic Nervous System
Autonomic Nervous System
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Sleep cycle
Sleep cycleSleep cycle
Sleep cycle
 
Sensory pathways.pptx
Sensory pathways.pptxSensory pathways.pptx
Sensory pathways.pptx
 
Neurotransmitter - Dopamine
Neurotransmitter - DopamineNeurotransmitter - Dopamine
Neurotransmitter - Dopamine
 
Endocrine pancreas
Endocrine pancreasEndocrine pancreas
Endocrine pancreas
 
Acetylcholine
AcetylcholineAcetylcholine
Acetylcholine
 
Adrenal medulla
Adrenal medullaAdrenal medulla
Adrenal medulla
 
Neurotransmitters
Neurotransmitters Neurotransmitters
Neurotransmitters
 
Adrenal medulla
Adrenal medullaAdrenal medulla
Adrenal medulla
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Somatosensory pathway
Somatosensory pathwaySomatosensory pathway
Somatosensory pathway
 
Novel neurotransmitters by Dr.JagMohan Prajapati
Novel neurotransmitters by Dr.JagMohan Prajapati Novel neurotransmitters by Dr.JagMohan Prajapati
Novel neurotransmitters by Dr.JagMohan Prajapati
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 

Viewers also liked

Viewers also liked (20)

Brain and behaviour dr vbk
Brain and behaviour   dr vbkBrain and behaviour   dr vbk
Brain and behaviour dr vbk
 
Brain And Behavior
Brain And BehaviorBrain And Behavior
Brain And Behavior
 
Chapter 2 Ap Psych- Brain & Behavior
Chapter 2 Ap Psych- Brain & BehaviorChapter 2 Ap Psych- Brain & Behavior
Chapter 2 Ap Psych- Brain & Behavior
 
The Brain & Behavior
The Brain & BehaviorThe Brain & Behavior
The Brain & Behavior
 
Prakash park
Prakash parkPrakash park
Prakash park
 
Assessment And Treatment Of Challenging Behaviors
Assessment And Treatment Of Challenging BehaviorsAssessment And Treatment Of Challenging Behaviors
Assessment And Treatment Of Challenging Behaviors
 
Brain and behaviour 2010
Brain and behaviour 2010Brain and behaviour 2010
Brain and behaviour 2010
 
Fighting Mr. Parkinson with Data: Round Three
Fighting Mr. Parkinson with Data: Round ThreeFighting Mr. Parkinson with Data: Round Three
Fighting Mr. Parkinson with Data: Round Three
 
Parkinson's disease - my friend
Parkinson's disease -  my friendParkinson's disease -  my friend
Parkinson's disease - my friend
 
Evidence Based Practices to Reduce Challenging Behavior
Evidence Based Practices to Reduce Challenging BehaviorEvidence Based Practices to Reduce Challenging Behavior
Evidence Based Practices to Reduce Challenging Behavior
 
Brain and behaviour newspaper article: Ethar Bashir
Brain and behaviour newspaper article: Ethar BashirBrain and behaviour newspaper article: Ethar Bashir
Brain and behaviour newspaper article: Ethar Bashir
 
Functions
FunctionsFunctions
Functions
 
Pacing
PacingPacing
Pacing
 
Hiv. walter sepulveda loyola.
Hiv. walter sepulveda loyola.Hiv. walter sepulveda loyola.
Hiv. walter sepulveda loyola.
 
Enf parkinson Tarea 4
Enf parkinson Tarea 4Enf parkinson Tarea 4
Enf parkinson Tarea 4
 
Parkinsons mn
Parkinsons mnParkinsons mn
Parkinsons mn
 
Parkinson Mestrado Universidade Estadual de Londrina
Parkinson Mestrado Universidade Estadual de LondrinaParkinson Mestrado Universidade Estadual de Londrina
Parkinson Mestrado Universidade Estadual de Londrina
 
Parkinson's disease an overview
Parkinson's disease an overviewParkinson's disease an overview
Parkinson's disease an overview
 
Get Sh!t Done
Get Sh!t DoneGet Sh!t Done
Get Sh!t Done
 
Recent advances in the management of parkinson disease
Recent advances in the management of parkinson diseaseRecent advances in the management of parkinson disease
Recent advances in the management of parkinson disease
 

Similar to The Brain And Human Behavior2

Y1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ NeurotransmittersY1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ Neurotransmitters
vajira54
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
guestf2e29f
 
CNS_Introduction1 .ppt
CNS_Introduction1 .pptCNS_Introduction1 .ppt
CNS_Introduction1 .ppt
dipika51
 
Neurotransmitter by Quratulain mughal
Neurotransmitter by Quratulain mughalNeurotransmitter by Quratulain mughal
Neurotransmitter by Quratulain mughal
QURATULAIN MUGHAL
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
damarisb
 
Drugsandthe Brain Part1 Review
Drugsandthe Brain Part1 ReviewDrugsandthe Brain Part1 Review
Drugsandthe Brain Part1 Review
vacagodx
 

Similar to The Brain And Human Behavior2 (20)

Normality and Abnormality
Normality and AbnormalityNormality and Abnormality
Normality and Abnormality
 
Y1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ NeurotransmittersY1S2 Synapse NMJ Neurotransmitters
Y1S2 Synapse NMJ Neurotransmitters
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Neurotramsitters and Neuromodulators SlideShare
 Neurotramsitters and Neuromodulators SlideShare  Neurotramsitters and Neuromodulators SlideShare
Neurotramsitters and Neuromodulators SlideShare
 
Neurohumoral transission in CNS
Neurohumoral transission in CNSNeurohumoral transission in CNS
Neurohumoral transission in CNS
 
CNS_Introduction1 .ppt
CNS_Introduction1 .pptCNS_Introduction1 .ppt
CNS_Introduction1 .ppt
 
Neuromodulation
NeuromodulationNeuromodulation
Neuromodulation
 
Neurohumoral transmission in central nervous system
Neurohumoral transmission in central nervous systemNeurohumoral transmission in central nervous system
Neurohumoral transmission in central nervous system
 
Neurohumoral transmission in CNS
Neurohumoral transmission in CNSNeurohumoral transmission in CNS
Neurohumoral transmission in CNS
 
neurohumoraltransmissionincns-210526115354.pdf
neurohumoraltransmissionincns-210526115354.pdfneurohumoraltransmissionincns-210526115354.pdf
neurohumoraltransmissionincns-210526115354.pdf
 
Neurotransmitter by Quratulain mughal
Neurotransmitter by Quratulain mughalNeurotransmitter by Quratulain mughal
Neurotransmitter by Quratulain mughal
 
Neurobiological Theories of Mental Disorders.ppt
Neurobiological Theories of Mental Disorders.pptNeurobiological Theories of Mental Disorders.ppt
Neurobiological Theories of Mental Disorders.ppt
 
Neurotransmiters 1
Neurotransmiters 1Neurotransmiters 1
Neurotransmiters 1
 
Neurohumoral transmission
Neurohumoral transmission Neurohumoral transmission
Neurohumoral transmission
 
Functions of neurotransmitters and neuropeptides
Functions of neurotransmitters and neuropeptidesFunctions of neurotransmitters and neuropeptides
Functions of neurotransmitters and neuropeptides
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Class intro to cns
Class intro to cnsClass intro to cns
Class intro to cns
 
Drugsandthe Brain Part1 Review
Drugsandthe Brain Part1 ReviewDrugsandthe Brain Part1 Review
Drugsandthe Brain Part1 Review
 

More from MD Specialclass (20)

Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...Applied nutrition   3 rd presentation - diseases of liver, gall bladder, and ...
Applied nutrition 3 rd presentation - diseases of liver, gall bladder, and ...
 
Git diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutritionGit diseases presentn no. 2 applied nutrition
Git diseases presentn no. 2 applied nutrition
 
Getting ahead of headaches
Getting ahead of headachesGetting ahead of headaches
Getting ahead of headaches
 
Acute brain attack 911
Acute brain attack  911Acute brain attack  911
Acute brain attack 911
 
Hema intro anemia
Hema intro anemiaHema intro anemia
Hema intro anemia
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL EXCRETA, SEWAGE, REFUSE DISPOSAL
EXCRETA, SEWAGE, REFUSE DISPOSAL
 
Fever & id diet final
Fever & id diet finalFever & id diet final
Fever & id diet final
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Hepatocellular carcinoma
Hepatocellular carcinomaHepatocellular carcinoma
Hepatocellular carcinoma
 
Eating disorders
Eating disordersEating disorders
Eating disorders
 
Normal sleep and sleep disorders
Normal sleep and sleep disordersNormal sleep and sleep disorders
Normal sleep and sleep disorders
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Thyroid
ThyroidThyroid
Thyroid
 
Dermatology dr.n.ramos
Dermatology   dr.n.ramosDermatology   dr.n.ramos
Dermatology dr.n.ramos
 
Tic disorder
Tic disorderTic disorder
Tic disorder
 
Toxic and drug induced hepatitis
Toxic and drug induced hepatitisToxic and drug induced hepatitis
Toxic and drug induced hepatitis
 
Pancreatic disease
Pancreatic diseasePancreatic disease
Pancreatic disease
 
Liver disease
Liver diseaseLiver disease
Liver disease
 
Complications of cirrhosis
Complications of cirrhosisComplications of cirrhosis
Complications of cirrhosis
 

The Brain And Human Behavior2

  • 1. Dr. Rene V. Yat The Brain and Human Behavior
  • 2.  
  • 3.  
  • 4.  
  • 5.  
  • 6.  
  • 7.  
  • 8.  
  • 9.  
  • 10.  
  • 11. Parts of basal ganglia
  • 12.  
  • 13.  
  • 14.
  • 15.  
  • 16.
  • 17.
  • 18. The dopamine pathways in schizophrenia In schizophrenia there is an increase in dopamine transmission between the substantia nigra to the caudate nucleus-putamen (neostriatum) compared with normal. While in the other major dopaminergic pathways — to the mesolimbic forebrain and the tubero-infundibular system — dopamine transmission is reduced. The dopamine hypothesis of schizophrenia proposes that increased levels of dopamine or dopamine receptors in the dorsal and or ventral striatum underlie the disorder.
  • 19. The glutamate pathways in a brain affected by schizophrenia In the normal brain the prominent glutaminergic pathways are: the cortico-cortical pathways; the pathways between the thalamus and the cortex; and the extrapyramidal pathway (the projections between the cortex and striatum). Other glutamate projections exist between the cortex, substantia nigra, subthalamic nucleus and pallidum.  The glutaminergic pathways are hypoactive in the brains of people diagnosed with schizophrenia and this is thought to cause the confusion and psychosis associated with the disorder.
  • 20. The serotonergic pathway showing the effects of schizophrenia The two key serotonergic pathways in schizophrenia are the projections from the dorsal raphe nuclei into the substantia nigra and the projections from the rostral raphe nuclei ascending into the cerebral cortex, limbic regions and basal ganglia. The up-regulation of these pathways leads to hypofunction of the dopaminergic system, and this effect may be responsible for the negative symptoms of schizophrenia. The serotonergic nuclei in the brainstem that give rise to descending serotonergic axons remain unaffected in schizophrenia.
  • 21.  
  • 22.  
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32. Neuropeptides Function of Neuropeptides:   There are cells in the brain that produce various neuropeptides, and these neuropeptides do just about everything.   They can be either pro-inflammatory or anti-inflammatory, with anti-inflammatory being preferred. They are responsible for many functions:   They control our mood, energy levels, pain and pleasure reception, body weight, and ability to solve problems; they also form memories and regulate our immune system.   These active little messengers in the brain actually turn on cellular function in the skin.
  • 33. Characteristics of Neuropeptides:   Peptides are compounds consisting of two or more amino acids (the building blocks of proteins), chained together by what is called a peptide bond.   Neuropeptides are peptides released by neurons (brain cells) as intercellular messengers. Some neuropeptides function as neurotransmitters, and others function as hormones.   Peptides and neuropeptides, like many substances in our bodies (think cholesterol) can work both for and against us. Anti-inflammatory neuropeptides work for us to reduce inflamation fo the skin.
  • 34. Transmitter names are shown in bold. Norepinephrine (noradrenaline). In neurons of the A2 cell group in the nucleus of the solitary tract ), norepinephrine co-exists with: Galanin Enkephalin Neuropeptide Y GABA Somatostatin (in the hippocampus ) Cholecystokinin Neuropeptide Y (in the arcuate nucleus ) Acetylcholine VIP Substance P - Originally nown as Tachykinins. Because they are rapidly absorbed they now known as neurokinins. They play a key role in modulation of pain and emotions. Hence possibly in the future this could be a source of new antidepresants PEPTIDES
  • 35. Dopamine Cholecystokinin Neurotensin Epinephrine (adrenaline) Neuropeptide Y Neurotensin Serotonin (5-HT) Substance P TRH Enkephalin PEPTIDES
  • 36.  
  • 37.  
  • 38. UPREGULATION HYPOTHESIS OF NEURONAL RECEPTORS
  • 39. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Supersensitivity is a compensatory response of the postsynaptic neuron when it receives too little stimulation. The neuron tries to make up for a lack of stimulation by increasing receptor responsiveness. Over time, the postsynaptic neuron may also compensate for lack of stimulation by synthesizing additional receptor sites. This process is known as up-regulation. Upregulation theory Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation) Supersensitivity (up-regulation)
  • 40. By increasing the amount of neurotransmitter in the cleft, you can normalize responsiveness. Increased neurotransmitter increases stimulation of receptor sites, which prompts the postsynaptic neuron to compensate by decreasing receptor sensitivity, a process known as desensitization DESENSITIZATION THEORY
  • 41. The postsynaptic neuron is also thought to compensate for increasing stimulation by decreasing the number of receptor sites, a process known as down-regulation. Downregulation hypothesis
  • 42.  
  • 43. “ Prolonged sitting can cause ischial bursitis”.
  • 44. “ To study medicine without books and mentors is like a shaman who professes who know everything but deep inside he knows nothing at all. You can shake, rattle, and roll. But at the end of the day, you wish that you have studied hard for the life you are handling in front of you is not a guinea pig at all”.
  • 45. END OF THE LECTURE